outcomes

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities

egowan — Thu, 02 Jan 2025 17:08:18 +0000

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities egowan Thu, 01/02/2025 - 12:08

This report presents results from the 2023 National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual survey of substance use and mental health treatment facilities in the United States.

Data Categories:

Mental Health Promotion Substance Abuse Prevention Suicide Prevention

National Survey Report

2023

Topics:

mental health outcomes

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2022: Data on Substance Use and Mental Health Treatment Facilities

Substance Abuse and Mental Health Services Administration. (2023). National Substance Use and Mental Health Services Survey (N-SUMHSS): Data on Substance Use and Mental Health Treatment Facilities. Publication No. PEP24-07- 027 MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2024. Retrieved from https://www.samhsa.gov/data/report/2023-n-sumhss-annual-report

National Estimates from Drug-Related Emergency Department Visits, 2023

egowan — Thu, 02 Jan 2025 15:40:37 +0000

National Estimates from Drug-Related Emergency Department Visits, 2023 egowan Thu, 01/02/2025 - 10:40

"In 2023, DAWN identified 138,859 (unweighted) drug-related ED visits from 53 participating hospitals. These data were analyzed to generate nationally representative weighted estimates for (1) all drug-related ED visits, (2) the top substances involved in drug-related ED visits, (3) opioid-related ED visits by type, and (4) polysubstance-related ED visits."

Data Categories:

Substance Abuse Prevention

National Report

2023

Topics:

alcohol opioids marijuana methamphetamines cocaine prescription drugs illicit drugs outcomes

Preliminary Findings from Drug-Related Emergency Department Visits, 2021

Findings from Drug-Related Emergency Department Visits, 2022

Substance Abuse and Mental Health Services Administration. (2024). Drug Abuse Warning Network: National Estimates from Drug-Related Emergency Department Visits, 2023. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data.

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose

egowan — Wed, 17 Jul 2024 19:41:30 +0000

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose egowan Wed, 07/17/2024 - 15:41

An 8-mg intranasal naloxone formulation, a higher-concentration product than had previously been available, was approved by the Food and Drug Administration (FDA) in 2021 for emergency treatment of known or suspected opioid overdose. This study examined outcomes among persons who received the 8-mg naloxone product and those who receive the usual 4-mg product to treat suspected overdose in New York state. New York State Department of Health (NYSDOH) partnered with New York State Police (NYSP) to field test 8-mg intranasal naloxone use by some NYSP troops.

Despite the increased naloxone concentration in the 8-mg intranasal product, no significant differences were found in the survival of aided persons, or the number of doses administered by law enforcement by formulation, suggesting that, in this field test, the increased dosage did not provide added benefit, even in light of the increased prevalence of synthetic opioids, including fentanyl, in the drug supply.

Data Categories:

Substance Abuse Prevention

MMW Report

2022-2023

Topics:

opioids outcomes

Payne ER, Stancliff S, Rowe K, Christie JA, Dailey MW. Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023. MMWR Morb Mortal Wkly Rep 2024;73:110–113. DOI: http://dx.doi.org/10.15585/mmwr.mm7305a4

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2022: Data on Substance Use and Mental Health Treatment Facilities

egowan — Thu, 02 Jan 2025 17:04:05 +0000

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2022: Data on Substance Use and Mental Health Treatment Facilities egowan Thu, 01/02/2025 - 12:04

This report presents results from the 2022 National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual survey of substance use and mental health treatment facilities in the United States.

Data Categories:

Mental Health Promotion Substance Abuse Prevention Suicide Prevention

National Survey Report

2022

Topics:

mental health outcomes

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities

Substance Abuse and Mental Health Services Administration. (2023). National Substance Use and Mental Health Services Survey (N-SUMHSS) 2022: Data on Substance Use and Mental Health Treatment Facilities (SAMHSA Publication No. PEP23-07-00-002).Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.

Findings from Drug-Related Emergency Department Visits, 2022

egowan — Thu, 02 Jan 2025 15:26:26 +0000

Findings from Drug-Related Emergency Department Visits, 2022 egowan Thu, 01/02/2025 - 10:26

"In 2022, the Drug Abuse Warning Network (DAWN) identified 143,596 (unweighted) drug-related emergency department (ED) visits from 53 participating hospitals. These data were analyzed to generate nationally representative weighted estimates (1) for all drug-related ED visits, (2) for the top drugs involved in drug-related ED visits, (3) for different opioid types involved in ED visits, (4) to describe polysubstance in ED visits, and (5) to identify newly mentioned drugs in 2022."

Data Categories:

Substance Abuse Prevention

National Report

2022

Topics:

alcohol opioids marijuana methamphetamines cocaine prescription drugs illicit drugs outcomes

Preliminary Findings from Drug-Related Emergency Department Visits, 2021

National Estimates from Drug-Related Emergency Department Visits, 2023

Substance Abuse and Mental Health Services Administration. (2023). Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2022 (HHS Publication No. PEP23-07-03-001). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.

Loneliness, Lack of Social and Emotional Support, and Mental Health Issues

egowan — Thu, 18 Jul 2024 15:38:14 +0000

Loneliness, Lack of Social and Emotional Support, and Mental Health Issues egowan Thu, 07/18/2024 - 11:38

The objectives of this study were to assess the association between social connection and mental health among U.S. adults and to determine the prevalence of loneliness, lack of social and emotional support, and mental health issues by demographic characteristics, including sexual orientation and gender identity. Prevalence estimates for stress, frequent mental distress, and history of depression were significantly higher among adults who reported loneliness and lack of social and emotional support than among those who did not. Prevalence was significantly higher among those who identified as gay, lesbian, bisexual, and something other than straight than among those who identified as straight.

Data Categories:

Mental Health Promotion

MMW Report

2022

Topics:

mental health outcomes

Bruss KV, Seth P, Zhao G. Loneliness, Lack of Social and Emotional Support, and Mental Health Issues — United States, 2022. MMWR Morb Mortal Wkly Rep 2024;73:539–545. DOI: http://dx.doi.org/10.15585/mmwr.mm7324a1

Provisional Mortality Data

mgowin — Tue, 09 May 2023 17:41:49 +0000

Provisional Mortality Data mgowin Tue, 05/09/2023 - 13:41

Based on the National Vital Statistics System data, unintentional injury was the third leading cause of death during 2022. Most unintentional injury deaths are drug overdose deaths.

Data Categories:

Substance Abuse Prevention

MMW Report

2022

Topics:

outcomes

Ahmad, F. B., et al. (2023). Provisional Mortality Data - United States, 2022. Morbidity and Mortality Weekly Report, 72(18): 488-492. https://www.cdc.gov/mmwr/volumes/72/wr/mm7218a3.htm?s_cid=mm7218a3_w

The Economic Toll of the Opioid Crisis Reached Nearly $1.5 Trillion in 2020

mgowin — Tue, 25 Oct 2022 17:12:49 +0000

The Economic Toll of the Opioid Crisis Reached Nearly $1.5 Trillion in 2020 mgowin Tue, 10/25/2022 - 13:12

"The Joint Economic Committee estimates that the opioid epidemic cost the United States nearly $1.5 trillion in 2020 alone - up 37% from 2017, when the CDC last measured the cost... more funding and action across federal, state, and local government is needed to better address the crisis at hand."

Data Categories:

Substance Abuse Prevention

National Report

2022

Topics:

opioids outcomes

Joint Economic Committee. (2022). The Economic Toll of the Opioid Crisis Reached Nearly $1.5 Trillion in 2020. https://www.jec.senate.gov/public/index.cfm/democrats/2022/9/jec-analysis-finds-opioid-epidemic-cost-u-s-nearly-1-5-trillion-in-2020

Treatment Episode Data Set (TEDS): 2021

egowan — Thu, 02 Jan 2025 16:46:52 +0000

Treatment Episode Data Set (TEDS): 2021 egowan Thu, 01/02/2025 - 11:46

"This report presents the total number of admissions to and discharges from substance use treatment services in 2021 by demographics, National Outcome Measures (NOMs), morbidity status, and the top six primary substances by geographic distribution."

Data Categories:

Substance Abuse Prevention

National Survey Report

2021

Topics:

alcohol heroin opioids marijuana cocaine methamphetamines stimulants outcomes

Treatment Episode Data Set (TEDS): 2016

Treatment Episode Data Set (TEDS): 2017

Treatment Episode Data Set (TEDS): 2018

Treatment Episode Data Set (TEDS): 2019

Treatment Episode Data Set (TEDS): 2020

Treatment Episode Data Set (TEDS): 2022

Substance Abuse and Mental Health Services Administration: Treatment Episode Data Set (TEDS) 2021: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies. Publication No. PEP23-07-00-004 MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2023. https://www.samhsa.gov/data/report/2021-teds-annual-report

Neonatal Abstinence Syndrome

mgowin — Tue, 02 May 2023 02:00:55 +0000

Neonatal Abstinence Syndrome mgowin Mon, 05/01/2023 - 22:00

Data Categories:

Substance Abuse Prevention

Interactive Dashboard

2021

Topics:

outcomes

Georgia Department of Public Health. (2021). Neonatal Abstinence Syndrome [data set]. Georgia Department of Behavioral Health & Developmental Disabilities. https://gaspsdata.net/data/neonatal-abstinence-syndrome